The researchers claim that UVA’s significant new results may one day allow physicians to increase microglia activation to treat or safeguard people with Alzheimer’s, Multiple Sclerosis, and other neurodegenerative disorders.
Researchers at UVA Health have discovered a brain chemical that coordinates the immune system’s responses to multiple sclerosis (MS) and Alzheimer’s disease, perhaps allowing healthcare providers to enhance the body’s capacity to fight these and other devastating neurological illnesses.
Scientists mainly used to disregard these immune cells, but they have recently emerged as crucial participants in maintaining brain health.
The researchers discovered that the kinase-like molecule is essential for clearing plaque formation linked to Alzheimer’s disease and avoiding the debris buildup that causes Multiple Sclerosis. The researchers demonstrated how it accomplishes this by controlling the activity of brain cleansers known as microglia. These immune cells were previously completely disregarded by scientists but have recently emerged as crucial participants in maintaining brain function.
